Mareike Weinschenk

Mareike Weinschenk has a background in scientific roles within the pharmaceutical industry. In 2018, they joined Vibalogics as a Scientist in USP Process Development, where they worked until 2021. In 2021, they transitioned to Celonic Group, starting as a Scientist in USP Early Phase before moving on to become a Process Lead in USP Clinical Supply in 2022.

Mareike Weinschenk completed their Bachelor of Science degree in Biochemistry at Ulm University in 2015. Mareike then pursued a Master of Science degree in the same field at the same university, which they completed in 2017. In 2017, they also worked on their Master Thesis at the DKFZ German Cancer Research Center.